Sustained Benefits of Deep Brain Stimulation of the Subthalamic Nucleus: A Five-year Analysis of an Implantable Neurostimulator for the Treatment of Parkinson’s disease (INTREPID) (P9-5.007)
The INTREPID study had two phases: a double-blind, sham-controlled, multicenter, randomized efficacy phase followed by an open-label phase. Here, we present outcomes from the 5-year open-label phase evaluating long-term effectiveness of subthalamic nucleus (STN) deep brain stimulation (DBS).
Authors
- Jerrold L. Vitek (ORCID: https://orcid.org/0000-0002-2308-6535)
- Rajat S. Shivacharan (ORCID: https://orcid.org/0000-0001-6824-4368)
- E. Matilda Goldberg
Institutions
- Boston Scientific (Netherlands) (NL)
- Neuromod (Ireland) (IE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208760
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00